Outlook Therapeutics Shares Plummet 48% After $5 Mln Offering and New 52-Week Low

Outlook Therapeutics' shares plummeted 48% to a 52-week low of $0.16 after pricing a $5 million offering of 20 million shares and warrants. The net proceeds will be used for working capital and general corporate purposes. The offering, expected to close on March 25, 2026, was led by H.C. Wainwright & Co. as the exclusive placement agent.